Items where Author is "Aigner, M."

Article

Singer, K. and Kastenberger, M. and Gottfried, E. and Hammerschmied, C. G. and Buettner, M. and Aigner, M. and Seliger, B. and Walter, B. and Schloesser, H. and Hartmann, A. and Andreesen, R. and Mackensen, A. and Kreutz, M. (2010) Warburg phenotype in renal cell carcinoma: High expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor. ONKOLOGIE, 33 (Suppl6). p. 128. ISSN 0378-584X

Singer, K. and Kastenberger, M. and Gottfried, E. and Hammerschmied, C. and Buettner, M. and Aigner, M. and Seliger, B. and Walter, B. and Hartmann, A. and Andreesen, R. and Mackensen, A. and Kreutz, M. (2010) Warburg phenotype in renal cell carcinoma: High expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T cell infiltrate in the tumor. EUROPEAN JOURNAL OF CELL BIOLOGY, 89 (Suppl1). p. 35. ISSN 0171-9335

Hoves, S. and Aigner, M. and Pfeiffer, C. and Laumer, M. and Obermann, E. C. and Mackensen, Andreas (2009) In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray. LEUKEMIA, 23 (5). pp. 877-885. ISSN 0887-6924, 1476-5551

Conference or Workshop Item

Mueller, F. and Schwingen, N. R. and Eisenhauer, N. and Aigner, M. and Schletter, M. and Lutzny-Geier, G. and Lischer, C. and Guese, E. and Gebhard, C. and Rehli, M. and Gonzalez, Vera J. and Eckstein, M. and Wiesmueller, M. and Erber, R. and Bruns, H. and Mackensen, A. and Voelkl, S. (2023) Oligoclonal expansion and loss of cytotoxic functionality of CAR-T cells in a DLBCL patient after CD19.CAR-T cell therapy. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Lischer, C. and Eisenhauer, N. and Aigner, M. and Jacobs, B. and Schletter, M. and Gebhard, C. and Rehli, Michael and Bruns, H. and Müller, F. and Mackensen, A. and Gonzalez, Vera J. and Völkl, S. (2022) Single-cell Transcriptome Analysis and clonal Kinetics in a Patient after CD19.CAR-T Cell Therapy. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Schneider-Brachert, W. and Decker, J. and Deml, L. and Aigner, M. and Knoll, G. and Lehn, Norbert (2001) Identification and characterisation of a 24 kDa Helicobacter pylori extracellular protein that induces high levels of IFN-gamma in mouse splenocytes. In: XIVth International Workshop on Gastroduodenal Pathology and Helicobacter pylori, September 5-8, 2001, Strasbourg, France.

Other

Strobl, C. D. and Henrich, F. C. and Singer, K. and Peter, K. and Kreutz, M. and Kremer, A. and Boettcher, M. and Mougiakakos, D. and Mackensen, A. and Aigner, M. (2017) Inhibition of human T cells by the tumor metabolite MTA: mechanism of action and MTAP-overexpression in T cells as putative strategy to improve antitumor activity. KARGER, BASEL.

Strobl, C. and Heinrich, F. F. and Singer, K. and Peter, K. and Kreutz, M. and Kremer, A. and Boettcher, M. and Mougiakakos, D. and Aigner, M. and Mackensen, A. (2017) Inhibition of human T cells by the tumor metabolite MTA: mechanism of action and MTAP-overexpression in T cells as putative strategy to improve antitumor activity. WILEY, HOBOKEN.

Strobl, C. and Henrich, F. and Peter, K. and Singer, K. and Kreutz, M. and Kremer, A. and Mackensen, A. and Aigner, M. (2016) MTA (5 '-deoxy-5 '-methylthioadenosine) suppresses function of human mDC and T cells and represents a mechanism of tumor immune escape. KARGER, BASEL.

Strobl, C. and Henrich, F. and Singer, K. and Gronwald, W. and Bosserhoff, A. and Kreutz, M. and Poller, K. and Kremer, A. and Mackensen, A. and Aigner, M. (2015) 5 '-deoxy-5 '-methylthioadenosine suppresses human T cell function and represents a novel mechanism of tumor immune escape. KARGER, BASEL.